Primary completion date changed
Before: 30 May 2027. After: 31 Jul 2027.
Study sponsor: TG Therapeutics, Inc. · TGTX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 30 May 2027. After: 31 Jul 2027.
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Part 2: Area under the curve (AUC) From Week 0 to Week 12 [AUC(0-W12)] of Ublituximab. After: Measure: Part 2: Area under the curve (AUC) at Steady State [AUCss] of Ublituximab.
Before: 31 Jul 2027. After: 30 May 2027.
Before: Not yet recruiting. After: Recruiting.